Recruiting XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer NCT06959641 Conditions Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +32 more Locations Harbor-UCLA Medical Center — Torrance, California, United States Northwestern University — Chicago, Illinois, United States View Trial Details
